{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:47:32Z","timestamp":1782546452513,"version":"3.54.5"},"reference-count":26,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Am Psychiatr Nurses Assoc"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Adolescents with attention-deficit\/hyperactivity disorder (ADHD) often require long-acting or pro-drug stimulants, but telehealth prescribing is constrained by the Ryan Haight Act\u2019s in-person requirements. While pandemic-era waivers temporarily lifted these mandates, their permanent status remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>Assess long-acting or pro-drug stimulant medication adherence using proportion of days covered (PDC) in adolescents with ADHD (12\u201317) receiving telehealth or hybrid care (2022\u20132024), comparing rates to post-pandemic (April 2020\u2013June 2022) adherence rates in urban pediatric populations. Examine symptom scores on the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Screening (GAD-2), and ADHD Symptom and Side Effect Tracking (ASSET). Compare visit attendance between telehealth and hybrid care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Program evaluation consisting of retrospective chart reviews, pre-visit surveys, and prescription data on 49 adolescents (21 telehealth and 28 hybrid) in a psychiatric clinic were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The total sample mean PDC was .381. Hybrid group adherence was .448 and .313 for the telehealth group. PDC was the same as the post-pandemic adherence rate (.310\u2013.440). Paired\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -tests comparing GAD-2 scores were (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; .001), PHQ-9 (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; .001), and ASSET (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .010). Telehealth attendance was lower than hybrid attendance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The hybrid care model showed better adherence and attendance than telehealth for adolescents with ADHD. PDC from this program evaluation was statistically similar to national trends in pediatric ADHD management. Future research must prioritize geographic and digital determinants, understand the impact of polypharmacy, and establish evidence-based strategies to enhance long-term adherence in telehealth care models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10783903261461212","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:48:44Z","timestamp":1782370124000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["A Program Evaluation of Medication Adherence With Long-Acting and Pro-Drug Stimulants in Adolescents Using Telehealth and Hybrid Care Models"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8836-829X","authenticated-orcid":false,"given":"Elizabeth","family":"Sweet","sequence":"first","affiliation":[{"name":"Duke University, Durham, NC, USA"},{"name":"RCBM, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. N.","family":"Powell","sequence":"additional","affiliation":[{"name":"RCBM, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8644-7676","authenticated-orcid":false,"given":"Jessica","family":"Marsack","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Fortain","sequence":"additional","affiliation":[{"name":"RCBM, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-9337","authenticated-orcid":false,"given":"Nancy","family":"Crego","sequence":"additional","affiliation":[{"name":"Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","unstructured":"American Academy of Child & Adolescent Psychiatry Telepsychiatry and Quality Committee. (2017). Clinical update: Telepsychiatry with children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry 56(10) 875\u2013893. https:\/\/doi.org\/10.1016\/j.jaacap.2017.07.019","DOI":"10.1016\/j.jaac.2017.07.008"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","unstructured":"Anghel L. A. Farcas A. M. Oprean R. N. (2019). An overview of the common methods used to measure treatment adherence. Medicine and Pharmacy Reports 92(2) 117\u2013122. https:\/\/doi.org\/10.15386\/mpr-1201","DOI":"10.15386\/mpr-1201"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.603303"},{"key":"e_1_3_2_5_1","unstructured":"Center for Connected Health Policy\/Public Health Institute. (2025). Medicare waiver expiration & telehealth FAQs. https:\/\/telehealthresourcecenter.org\/wp-content\/uploads\/2025\/10\/FAQs-Medicare-Telehealth-Flexibility-End-11.7-Final.pdf"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","unstructured":"Chuo J. Macy M. L. Lorch S. A. (2020). Strategies for evaluating telehealth. Pediatrics 146(5) Article e20201781. https:\/\/doi.org\/10.1542\/peds.2020-1781","DOI":"10.1542\/peds.2020-1781"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","unstructured":"Cunniff P. J. Ahsan A. McCrary C. Wang G. (2024). ADHD prescription patterns and medication adherence in children and adolescents during the COVID-19 pandemic in an urban academic setting. BMC Psychiatry 24(188) Article 1\u201311. https:\/\/doi.org\/10.1186\/s12888-024-05623-4","DOI":"10.1186\/s12888-024-05623-4"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","unstructured":"Cunningham N. R. Ely S. L. Barber Garcia B. N. Bowden J. (2021). Addressing pediatric mental health using telehealth during coronavirus disease-2019 and beyond: A narrative review. Academic Pediatrics 21(7) 1108\u20131117. https:\/\/doi.org\/10.1016\/j.acap.2021.06.002","DOI":"10.1016\/j.acap.2021.06.002"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","unstructured":"Danielson M. L. Claussen A. H. Bitsko R. H. Katz S. M. Newsome K. Blumberg S. J. Kogan M. D. Ghandour R. (2024). ADHD prevalence among U.S. children and adolescents in 2022: Diagnosis severity co-occurring disorders and treatment. Journal of Clinical Child and Adolescent Psychology: The Official Journal for the Society of Clinical Child and Adolescent Psychology American Psychological Association Division 53(3) 343\u2013360. https:\/\/doi.org\/10.1080\/15374416.2024.2335625","DOI":"10.1080\/15374416.2024.2335625"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","unstructured":"Dulude C. Sutherland S. Vanderhout S. King W. J. Zuijdwijk C. Major N. Audcent T. Howley H. Cloutier P. Buba M. Jain R. Litwinska J. Findlay L. Malic C. Macaulay K. Parker K. Kouri C. Goldbloom E. B. (2023). A pediatric virtual care evaluation framework and its evolution using consensus methods. BMC Pediatrics 23(1) Article 402. https:\/\/doi.org\/10.1186\/s12887-023-04229-1","DOI":"10.1186\/s12887-023-04229-1"},{"key":"e_1_3_2_11_1","unstructured":"Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications 89 Fed. Reg. 91557 (Nov. 19 2024) (to be codified at 21 C.F.R. pt. 1306). https:\/\/www.federalregister.gov\/documents\/2024\/11\/19\/2024-26815\/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-P\u00e9rez L. Linertov\u00e1 R. Serrano-P\u00e9rez P. Trujillo-Mart\u00edn M. Rodr\u00edguez-Rodr\u00edguez L. Valc\u00e1rcel-Nazco C. Del Pino-Sede\u00f1o T. (2020). Interventions to improve medication adherence in mental health: The update of a systematic review of cost-effectiveness. International Journal of Psychiatry in Clinical Practice 24(4) 416\u2013427. https:\/\/doi.org\/10.1080\/13651501.2020.1782434","DOI":"10.1080\/13651501.2020.1782434"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","unstructured":"Khan M. U. Aslani P. (2020). A review of measures used to examine medication adherence in people with ADHD at initiation implementation and discontinuation of pharmacotherapy. Research in Social & Administrative Pharmacy: RSAP 16(3) 277\u2013289. https:\/\/doi.org\/10.1016\/j.sapharm.2019.06.001","DOI":"10.1016\/j.sapharm.2019.06.001"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"McCabe S. E. Schulenberg J. E. Wilens T. E. Schepis T. S. McCabe V. V. Veliz P. T. (2023). Prescription stimulant medical and nonmedical use among US secondary school students 2005 to 2020. JAMA Network Open 6(4) e238707. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.8707","DOI":"10.1001\/jamanetworkopen.2023.8707"},{"key":"e_1_3_2_15_1","unstructured":"MedaData. (n.d.). The ADHD Symptom and Side Effect Tracking (ASSET) tool. https:\/\/www.medadataresearch.com\/asset\/"},{"key":"e_1_3_2_16_1","author":"Microsoft Corporation","year":"2019","unstructured":"Microsoft Corporation. (2019). Microsoft excel (Version 2019) [Computer software].","journal-title":"Microsoft excel"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","unstructured":"Myers K. Nelson E.-L. Rabinowitz T. Hilty D. Baker D. McClay M. (2017). American telemedicine association practice guidelines for telemental health with children and adolescents. Telemedicine and e-Health 23(10) 779\u2013804. https:\/\/doi.org\/10.1089\/tmj.2017.0177","DOI":"10.1089\/tmj.2017.0177"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","unstructured":"Nasser A. AlSubaie A. S. Al-Hadi A. S. Al-Saffar A. Al-Khalaf A. S. (2022). Psychometric properties of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) among patients in primary care. International Journal of Mental Health Nursing 31(2) 456\u2013468. https:\/\/doi.org\/10.1111\/inm.12942","DOI":"10.1111\/inm.12942"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","unstructured":"Rao V. Lanni S. Yule A. M. McCabe S. E. Veliz P. T. Schepis T. S. Wilens T. E. (2025). Telehealth prescribing of stimulants for ADHD and associated risk for later stimulant and substance use disorders. The American Journal of Psychiatry 182(8) 779\u2013788. https:\/\/doi.org\/10.1176\/appi.ajp.20240346","DOI":"10.1176\/appi.ajp.20240346"},{"key":"e_1_3_2_20_1","unstructured":"Ryan Haight Online Pharmacy Consumer Protection Act of 2008 Pub. L. No. 110\u2013425 122 Stat. 4820 (2008)."},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","unstructured":"Shamoon U. Jafri H. Ahmed A. Shamoon Y. Narvaneni S. (2024). A retrospective chart review evaluating the changes in depressive symptoms in adult patients with Attention-Deficit\/Hyperactivity Disorder (ADHD) with the treatment of the underlying ADHD. Cureus 16(4) Article e57448. https:\/\/doi.org\/10.7759\/cureus.57448","DOI":"10.7759\/cureus.57473"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","unstructured":"Storetvedt M. H. R. Kahlon S. Berg K. Sundfjord I. A. Nordgreen T. (2024). Development of a digital mental health intervention for youth with ADHD: Exploring youth perspectives on wants needs and barriers. Frontiers in Digital Health 6 Article 1386892. https:\/\/doi.org\/10.3389\/fdgth.2024.1386892","DOI":"10.3389\/fdgth.2024.1386892"},{"key":"e_1_3_2_23_1","unstructured":"VGM & Associates. (2025 August 25). CONNECT for health act gains bipartisan momentum to expand telehealth access. https:\/\/www.vgm.com\/services\/government-relations\/connect-for-health-act-gains-bipartisan-momentum-to-expand-telehealth-access-\/"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","unstructured":"Worthen A. Torous J. Khan S. Hammes N. Rabinowitz T. (2024). Telepsychiatry current practice and implications for future trends: A 2023 American psychiatric association member survey. Telemedicine Journal and e-health: The Official Journal of the American Telemedicine Association 30(11) 2662\u20132668. https:\/\/doi.org\/10.1089\/tmj.2024.0042","DOI":"10.1089\/tmj.2024.0042"},{"key":"e_1_3_2_25_1","volume-title":"ADHD sensitivity to comprehensive treatment: An evaluation of improvement in ADHD symptom severity as an indicator of improvement in depressive and anxious symptom severity","author":"Young J.","year":"2024","unstructured":"Young J., Powell R., Powell A., Welling L., Saal J., Nash M. (2024, January). ADHD sensitivity to comprehensive treatment: An evaluation of improvement in ADHD symptom severity as an indicator of improvement in depressive and anxious symptom severity [Conference poster presentation]. American Professional Society of ADHD and Related Disorders, 2024 Conference, Orlando, FL, United States."},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-05295-6"},{"key":"e_1_3_2_27_1","doi-asserted-by":"crossref","unstructured":"Zimmerman M. Walsh E. Friedman M. Boerescu D. A. Attiullah N. (2018). Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice? Journal of Affective Disorders 225 449\u2013452. https:\/\/doi.org\/10.1016\/j.jad.2017.08.024","DOI":"10.1016\/j.jad.2017.08.024"}],"container-title":["Journal of the American Psychiatric Nurses Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10783903261461212","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10783903261461212","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10783903261461212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:17:19Z","timestamp":1782544639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10783903261461212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":26,"alternative-id":["10.1177\/10783903261461212"],"URL":"https:\/\/doi.org\/10.1177\/10783903261461212","relation":{},"ISSN":["1078-3903","1532-5725"],"issn-type":[{"value":"1078-3903","type":"print"},{"value":"1532-5725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"10783903261461212"}}